Reports of this serious neurological illness was also at the heart of trial halts in the early stages of development for both AstraZeneca and J&J’s COVID-19 shots. Source

JOIN NCOV.LINK NEWSLETTER

And get notified everytime we publish a new Important announcements. We will not email you often, unless there are important things that need to get in touch with you, such as added new tools or new domain names.